Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors. Peyraud F, Guegan JP, Bodet D, Nafia I, et al. Ann Oncol 2022;33:1041-1051.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Peyraud F, Guegan JP, Bodet D, Nafia I, et al. Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors. Ann Oncol 2022;33:1041-1051.
PMID: 35850444